CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 39 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,482,591 | +259.8% | 99,436 | +164.2% | 0.00% | – |
| Q2 2023 | $412,049 | +284.0% | 37,630 | +9.1% | 0.00% | – |
| Q1 2022 | $107,311 | -19.3% | 34,505 | -12.0% | 0.00% | – |
| Q4 2021 | $133,000 | +64.2% | 39,219 | +76.1% | 0.00% | – |
| Q3 2021 | $81,000 | -56.5% | 22,272 | -47.9% | 0.00% | – |
| Q2 2021 | $186,000 | -1.6% | 42,743 | +2.4% | 0.00% | – |
| Q1 2021 | $189,000 | -20.3% | 41,734 | +1.2% | 0.00% | – |
| Q4 2020 | $237,000 | -19.1% | 41,254 | +2.0% | 0.00% | – |
| Q3 2020 | $293,000 | +96.6% | 40,426 | -3.6% | 0.00% | – |
| Q2 2020 | $149,000 | +115.9% | 41,925 | -9.8% | 0.00% | – |
| Q1 2020 | $69,000 | -14.8% | 46,461 | +12.9% | 0.00% | – |
| Q4 2019 | $81,000 | -63.2% | 41,169 | -3.0% | 0.00% | – |
| Q3 2019 | $220,000 | -27.6% | 42,430 | 0.0% | 0.00% | – |
| Q2 2019 | $304,000 | -39.2% | 42,430 | +12.5% | 0.00% | -100.0% |
| Q1 2019 | $500,000 | +73.0% | 37,701 | +2.7% | 0.00% | – |
| Q4 2018 | $289,000 | -31.0% | 36,716 | -3.1% | 0.00% | – |
| Q3 2018 | $419,000 | -26.6% | 37,883 | -11.0% | 0.00% | -100.0% |
| Q2 2018 | $571,000 | +57000.0% | 42,572 | +16465.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 257 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | – | 257 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 257 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | – | 257 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 257 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 257 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 257 | 0.0% | 0.00% | – |
| Q3 2015 | $1,000 | 0.0% | 257 | 0.0% | 0.00% | – |
| Q2 2015 | $1,000 | -50.0% | 257 | 0.0% | 0.00% | – |
| Q1 2015 | $2,000 | -33.3% | 257 | 0.0% | 0.00% | – |
| Q4 2014 | $3,000 | – | 257 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,254,502 | $20,741,000 | 14.54% |
| Versant Venture Management, LLC | 1,048,601 | $9,647,127,000 | 10.15% |
| Abingworth LLP | 1,147,077 | $10,553,000 | 7.65% |
| Omega Fund Management, LLC | 551,477 | $5,074,000 | 3.67% |
| Opaleye Management Inc. | 665,000 | $6,118,000 | 1.96% |
| DAFNA Capital Management LLC | 361,164 | $3,323,000 | 1.79% |
| Boxer Capital, LLC | 1,012,986 | $9,319,000 | 1.70% |
| Foresite Capital Management III, LLC | 600,000 | $5,520,000 | 1.55% |
| NEXTHERA CAPITAL LP | 536,568 | $4,936,000 | 0.91% |
| Perceptive Advisors | 2,685,882 | $24,710,000 | 0.82% |